JNK, c-Jun NH2-terminal kinase
- You have accessmTOR Inhibition by Rapamycin Prevents β-Cell Adaptation to Hyperglycemia and Exacerbates the Metabolic State in Type 2 DiabetesMerav Fraenkel, Mali Ketzinel-Gilad, Yafa Ariav, Orit Pappo, Melis Karaca, Julien Castel, Marie-France Berthault, Christophe Magnan, Erol Cerasi, Nurit Kaiser, Gil LeibowitzDiabetes Apr 2008, 57 (4) 945-957; DOI: 10.2337/db07-0922
- You have accessTherapeutic Potential of Peroxisome Proliferators–Activated Receptor-α/γ Dual Agonist With Alleviation of Endoplasmic Reticulum Stress for the Treatment of DiabetesKyu Lee Han, Joo Sun Choi, Jae Young Lee, Jihyun Song, Myung Kuk Joe, Myeong Ho Jung, Jae-Kwan HwangDiabetes Mar 2008, 57 (3) 737-745; DOI: 10.2337/db07-0972
- You have accessLoss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin ResistanceDaniela M.L. Tsukumo, Marco A. Carvalho-Filho, José B.C. Carvalheira, Patrícia O. Prada, Sandro M. Hirabara, André A. Schenka, Eliana P. Araújo, José Vassallo, Rui Curi, Lício A. Velloso, Mario J.A. SaadDiabetes Aug 2007, 56 (8) 1986-1998; DOI: 10.2337/db06-1595
- Diabetes Education (124)
- Epidemiology-Aging (30)
- Epidemiology-Other (230)
- Exercise (54)
- Heart Failure (6)
- Immunology (88)
- Nutrition-Clinical (55)
- Obesity-Animal (60)
- Obesity-Human (74)
- Profiles in Progress (29)
- The RISE Consortium (13)
- Therapeutic Inertia (17)
- Transplantation (16)